Nutrigenetic associations with cardiovascular disease

Reviews in Cardiovascular Medicine

Volumn 15, Issue 3, 2014, Pages 217-225

  Nuno, Natasha Bushnell ^a   Heuberger, Roschelle ^a  

^a CENTRAL MICHIGAN UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Diet; Genetics; Nutrigenetics

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACYL COENZYME A DESATURASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A5; ARACHIDONATE 5 LIPOXYGENASE; CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TRIACYLGLYCEROL;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL GENETICS; DISEASE ASSOCIATION; FAT INTAKE; GENETIC POLYMORPHISM; HUMAN; NUTRIGENETICS; NUTRIGENOMICS; NUTRITION; PROTEIN BLOOD LEVEL; REVIEW;

EID: 84908249038     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: 10.3909/ricm0658     Document Type: Review

References (31)

1. Roger VL, Go AS, Lloyd-Jones DM, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistic-2011 update: a report from the American Heart Association. Circulation. 2011;123: e18-e209.
2. Bennet AM, Di Angelantonio E, Ye Z, et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA. 2007;298:1300-1311.
3. Lopez-Miranda J, Ordovas JM, Mata P, et al. Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res. 1994;35:1965-1975.
4. Mosher MJ, Lange LA, Howard BV, et al. Sex-specific interaction between APOE genotype and carbohydrate intake affects plasma HDL-C levels: the Strong Heart Family Study. Genes Nutr. 2008;3:87-97.
5. Moreno JA, Perez-Jimenez F, Marin C, et al. Apolipoprotein E gene promoter -219G-.T polymorphism increases LDL-cholesterol concentrations and susceptibility to oxidation in response to a diet rich in saturated fat. Am J Clin Nutr. 2004;80:1404-1409.
6. Moreno JA, Perez-Jimenez F, Moreno-Luna R, et al. The effect of apoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects. Br J Nutr. 2009;101:1745-1752.
7. Robitaille J, Perusse L, Bouchard C, Vohl MC. Genes, fat intake, and cardiovascular disease risk factors in the Quebec Family Study. Obesity. 2007;15: 2336-2347.
8. Caslake MJ, Miles EA, Kofler BM, et al. Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Am J Clin Nutr. 2008;88:618-629.
9. Lu Y, Feskens EJ, Dolle ME, et al. Dietary n-3 and n-6 polyunsaturated fatty acid intake interacts with FADS1 genetic variation to affect total and HDLcholesterol concentrations in the Doetinchem Cohort Study. Am J Clin Nutr. 2010;92:258-265.
10. Dumont J, Huybrechts I, Spinneker A, et al; HELENA Study group. FADS1 genetic variability interacts with dietary α-linolenic acid intake to affect serum non-HDL-cholesterol concentrations in European adolescents. J Nutr. 2011;141:1247-1253.
11. Dwyer JH, Allayee H, Dwyer KM, et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med. 2004;350:29-37.
12. Allayee H, Baylin A, Hartiala J, et al. Nutrigenetic association of the 5-lipoxygenase gene with myocardial infarction. Am J Clin Nutr. 2008;88:934-940.
13. Volcik KA, Nettleton JA, Ballantyne CM, Boerwinkle E. Peroxisome proliferator-Activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study. Am J Clin Nutr. 2008;87:1926-1931.
14. Chan E, Tan CS, Deurenberg-Yap M, et al. The V227A polymorphism at the PPARA locus is associated with serum lipid concentrations and modulates the association between dietary polyunsaturated fatty acid intake and serum high density lipoprotein concentrations in Chinese women. Atherosclerosis. 2006;187:309-315.
15. Paradis AM, Fontaine-Bisson B, Bosse Y, et al. The peroxisome proliferator-Activated receptor alpha Leu162Val polymorphism influences the metabolic response to a dietary intervention altering fatty acid proportions in healthy men. Am J Clin Nutr. 2005;81:523-530.
16. Tanaka T, Ordovas JM, Delgado-Lista J, et al. Peroxisome proliferator-Activated receptor alpha polymorphisms and postprandial lipemia in healthy men. J Lipid Res. 2007;48:1402-1408.
17. Rudkowska I, Garenc C, Couture P, Vohl MC. Omega-3 fatty acids regulate gene expression levels differently in subjects carrying the PPARalpha L162V polymorphism. Genes Nutr. 2009;4:199-205.
18. Tai ES, Corella D, Demissie S, et al; Framingham Heart Study. Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study. J Nutr. 2005;135:397-403.
19. Caron-Dorval D, Paquet P, Paradis AM, et al. Effect of the PPAR-Alpha L162V polymorphism on the cardiovascular disease risk factor in response to n-3 polyunsaturated fatty acids. J Nutrigenet Nutrigenomics. 2008;1:205-212.
20. Ordovas JM, Corella D, Cupples LA, et al. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study. Am J Clin Nutr. 2002;75:38-46.
21. Gomez P, Perez-Martinez P, Marin C, et al. APOA1 and APOA4 gene polymorphisms influence the effects of dietary fat on LDL particle size and oxidation in healthy young adults. J Nutr. 2010;140:773-778.
22. Corella D, Peloso G, Arnett DK, et al. APOA2, dietary fat and body mass index: replication of a gene-diet interaction in three independent populations. Arch Intern Med. 2009;169:1897-1906.
23. Corella D, Tai ES, Sorli JV, et al. Association between the APOA2 promoter polymorphism and body weight in Mediterranean and Asian populations: replication of a gene-saturated fat interaction. Int J Obes (Lond). 2011;35:666-675.
24. Corella D, Lai CQ, Demissie S, et al. APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study. J Mol Med. 2007;85:119-128.
25. Sanchez-Moreno C, Ordovas JM, Smith CE, et al. APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population. J Nutr. 2011;141: 380-385.
26. Lai CQ, Corella D, Demissie S, et al. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study. Circulation. 2006;113:2062-2070.
27. Pitsavos C, Panagiotakos D, Trichopoulou A, et al. Interaction between Mediterranean diet and methylenetetrahydrofolate reductase C677T mutation on oxidized low density lipoprotein concentrations: the ATTICA study. Nutr Metab Cardiovasc Dis. 2006;16:91-99.
28. Dedoussis GV, Panagiotakos DB, Chrysohoou C, et al. Effect of interaction between adherence to a Mediterranean diet and the methylenetetrahydrofolate reductase 677C?T mutation on homocysteine concentrations in healthy adults: the ATTICA Study. A J Clin Nutr. 2004;80:849-854.
29. Zee RY, Mora S, Cheng S, et al. Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C.T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women. Clin Chem. 2007;53:845-851.
30. Holmes MV, Newcombe P, Hubacek JA, et al. Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-Analysis of genetic studies and randomised trials. Lancet. 2011;378:584-594.
31. Arkadianos I, Valdes AM, Marinos E, et al. Improved weight management using genetic information to personalize a calorie controlled diet. Nutr J. 2007; 6:29.